Serum Institute Of India will provide 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme, as a part of a brand new long-term deal, the pinnacle of the UN Kids’s Fund stated on Wednesday.
UNICEF chief Henrietta Fore stated the pictures could be delivered over a lot of years at the price of about $three per dose for low- and middle-income international locations.
They might be produced by Serum beneath a expertise switch settlement, she stated in a briefing.
The deal is on prime of the objective of distributing 2 billion doses of vaccines to poor international locations this 12 months beneath the COVAX facility, which is co-led by GAVI, the World Well being Group, the Coalition for Epidemic Preparedness Improvements (CEPI) and UNICEF.
UNICEF has additionally stockpiled 500 million syringes amongst different tools in preparation for the roll-out of pictures beginning within the subsequent few weeks, Fore stated.
CEPI is working with vaccine builders to be as prepared as doable to cope with adjustments wanted to vaccines to make sure they work in opposition to extra infectious COVID-19 variants which have emerged up to now few months, deputy CEO of CEPI Frederik Kristensen informed the briefing.